CVS HEALTH Corp bought a new position in shares of Vanguard Intermediate-Term Corporate Bond ETF (NASDAQ:VCIT – Free Report) in the third quarter, HoldingsChannel reports. The firm bought 60,000 shares of the company’s stock, valued at approximately $4,699,000. Vanguard Intermediate-Term Corporate Bond ETF makes up approximately 1.1% of CVS HEALTH Corp’s investment portfolio, making the stock its 21st largest holding.
Other hedge funds have also modified their holdings of the company. Eaton Cambridge Inc. boosted its position in shares of Vanguard Intermediate-Term Corporate Bond ETF by 3.7% during the 1st quarter. Eaton Cambridge Inc. now owns 3,874 shares of the company’s stock worth $321,000 after purchasing an additional 137 shares in the last quarter. Atomic Invest LLC increased its holdings in shares of Vanguard Intermediate-Term Corporate Bond ETF by 2.0% in the 2nd quarter. Atomic Invest LLC now owns 7,023 shares of the company’s stock valued at $583,000 after purchasing an additional 137 shares in the last quarter. OxenFree Capital LLC increased its holdings in shares of Vanguard Intermediate-Term Corporate Bond ETF by 0.3% in the 2nd quarter. OxenFree Capital LLC now owns 44,096 shares of the company’s stock valued at $3,614,000 after purchasing an additional 140 shares in the last quarter. Planning Strategies Inc. increased its holdings in shares of Vanguard Intermediate-Term Corporate Bond ETF by 0.3% in the 3rd quarter. Planning Strategies Inc. now owns 44,164 shares of the company’s stock valued at $3,458,000 after purchasing an additional 145 shares in the last quarter. Finally, AlphaCore Capital LLC lifted its stake in shares of Vanguard Intermediate-Term Corporate Bond ETF by 10.5% in the third quarter. AlphaCore Capital LLC now owns 1,540 shares of the company’s stock valued at $121,000 after purchasing an additional 146 shares during the period.
Vanguard Intermediate-Term Corporate Bond ETF Trading Up 0.0%
Shares of NASDAQ VCIT opened at $79.30 on Thursday. Vanguard Intermediate-Term Corporate Bond ETF has a 52 week low of $77.61 and a 52 week high of $84.84. The firm has a 50-day moving average price of $79.22 and a 200 day moving average price of $81.75.
About Vanguard Intermediate-Term Corporate Bond ETF
Vanguard Intermediate-Term Corporate Bond ETF seeks to track the performance of the Barclays Capital U.S. 5-10 Year Corporate Bond Index, a subset of the Barclays Capital U.S. Aggregate Float Adjusted Index. The Barclays Capital U.S. 5-10 Year Corporate Bond Index measures the investment return of U.S. dollar denominated, investment-grade, fixed rate, taxable securities issued by industrial, utility, and financial companies with maturities between 5 and 10 years. Vanguard Group, Inc. provides investment adisory services to the Fund.
See Also
- Five stocks we like better than Vanguard Intermediate-Term Corporate Bond ETF
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Want to see what other hedge funds are holding VCIT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vanguard Intermediate-Term Corporate Bond ETF (NASDAQ:VCIT – Free Report).
Receive News & Ratings for Vanguard Intermediate-Term Corporate Bond ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vanguard Intermediate-Term Corporate Bond ETF and related companies with MarketBeat.com's FREE daily email newsletter.
